MARIELYS MARTINEZ ALEMAN: Open Payments
NPI 1144836859 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$736 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $475 · 2025 $736
Food & beverage: $736
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $224 |
| Neurocrine BioSciences, Inc. | 3 | $143 |
| Alpha Cognition USA, Inc. | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $107 |
| ACADIA Pharmaceuticals Inc | 1 | $87 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| ABBVIE INC. | 1 | $24 |
Products named: REXULTI, INGREZZA, Zunveyl, AUSTEDO XR, NUPLAZID, COBENFY, NATRELLE SALINE-FILLED BREAST IMPLANTS.
Industry payments across FL — which companies pay providers there.
